Skip to content

Eikon Therapeutics, Inc.

EIKN· NasdaqCore metricsCIK 1861123

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -9.02%
Market cap
$327.83M
54.19M shares
Filings
69
—
—
—
-$86.11M
Q3 2026
—
-$90.55M
Q3 2026
—
-$224.88M
Q3 2026derived
—
-$1.59
Q3 2026
—
$98.48M
Q3 2026
—
$327.83M
—
—
0.9×
—
—

FY2026 figures · derived

Price

$6.0559.67%$8.95since Feb 5, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Net Interest Income

$4.49MQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Biological products, except diagnostic substances

Eikon Therapeutics, Inc. is the 74th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Eikon Therapeutics, Inc. · CIK 1861123 · Engraved from SEC EDGAR